These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 33862002)

  • 1. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
    Petit C; Lacas B; Pignon JP; Le QT; Grégoire V; Grau C; Hackshaw A; Zackrisson B; Parmar MKB; Lee JW; Ghi MG; Sanguineti G; Temam S; Cheugoua-Zanetsie M; O'Sullivan B; Posner MR; Vokes EE; Cruz Hernandez JJ; Szutkowski Z; Lartigau E; Budach V; Suwiński R; Poulsen M; Kumar S; Ghosh Laskar S; Mazeron JJ; Jeremic B; Simes J; Zhong LP; Overgaard J; Fortpied C; Torres-Saavedra P; Bourhis J; Aupérin A; Blanchard P;
    Lancet Oncol; 2021 May; 22(5):727-736. PubMed ID: 33862002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis.
    Petit C; Lee A; Ma J; Lacas B; Ng WT; Chan ATC; Hong RL; Chen MY; Chen L; Li WF; Huang PY; Tan T; Ngan RKC; Zhu G; Mai HQ; Hui EP; Fountzilas G; Zhang L; Carmel A; Kwong DLW; Moon J; Bourhis J; Auperin A; Pignon JP; Blanchard P;
    Lancet Oncol; 2023 Jun; 24(6):611-623. PubMed ID: 37269842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial.
    Bourhis J; Sire C; Graff P; Grégoire V; Maingon P; Calais G; Gery B; Martin L; Alfonsi M; Desprez P; Pignon T; Bardet E; Rives M; Geoffrois L; Daly-Schveitzer N; Sen S; Tuchais C; Dupuis O; Guerif S; Lapeyre M; Favrel V; Hamoir M; Lusinchi A; Temam S; Pinna A; Tao YG; Blanchard P; Aupérin A
    Lancet Oncol; 2012 Feb; 13(2):145-53. PubMed ID: 22261362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
    Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
    Yuan J; Shi K; Chen G; Xu W; Qiu L; Fei Y; Zhu Y; Wu M; Li Y; Sun X; Cao Y; Zhou S
    Cancer Control; 2024; 31():10732748241255535. PubMed ID: 38773761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial.
    Giralt J; Trigo J; Nuyts S; Ozsahin M; Skladowski K; Hatoum G; Daisne JF; Yunes Ancona AC; Cmelak A; Mesía R; Zhang A; Oliner KS; VanderWalde A
    Lancet Oncol; 2015 Feb; 16(2):221-32. PubMed ID: 25596659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperfractionated or accelerated radiotherapy for head and neck cancer.
    Baujat B; Bourhis J; Blanchard P; Overgaard J; Ang KK; Saunders M; Le Maître A; Bernier J; Horiot JC; Maillard E; Pajak TF; Poulsen MG; Bourredjem A; O'Sullivan B; Dobrowsky W; Andrzej H; Skladowski K; Hay JH; Pinto LH; Fu KK; Fallai C; Sylvester R; Pignon JP;
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD002026. PubMed ID: 21154350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy with lobaplatin and fluorouracil versus cisplatin and fluorouracil followed by chemoradiotherapy in patients with stage III-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised, controlled, phase 3 trial.
    Lv X; Cao X; Xia WX; Liu KY; Qiang MY; Guo L; Qian CN; Cao KJ; Mo HY; Li XM; Li ZH; Han F; He YX; Liu YM; Wu SX; Bai YR; Ke LR; Qiu WZ; Liang H; Liu GY; Miao JJ; Li WZ; Lv SH; Chen X; Zhao C; Xiang YQ; Guo X
    Lancet Oncol; 2021 May; 22(5):716-726. PubMed ID: 33857411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
    Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
    Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
    Michiels S; Le Maître A; Buyse M; Burzykowski T; Maillard E; Bogaerts J; Vermorken JB; Budach W; Pajak TF; Ang KK; Bourhis J; Pignon JP;
    Lancet Oncol; 2009 Apr; 10(4):341-50. PubMed ID: 19246242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.
    Mesía R; Henke M; Fortin A; Minn H; Yunes Ancona AC; Cmelak A; Markowitz AB; Hotte SJ; Singh S; Chan AT; Merlano MC; Skladowski K; Zhang A; Oliner KS; VanderWalde A; Giralt J
    Lancet Oncol; 2015 Feb; 16(2):208-20. PubMed ID: 25596660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
    Dauzier E; Lacas B; Blanchard P; Le QT; Simon C; Wolf G; Janot F; Horiuchi M; Tobias JS; Moon J; Simes J; Deshmane V; Mazeron JJ; Mehta S; Zaktonik B; Tamura M; Moyal E; Licitra L; Fortpied C; Haffty BG; Ghi MG; Gregoire V; Harris J; Bourhis J; Aupérin A; Pignon JP;
    Oral Oncol; 2019 Aug; 95():106-114. PubMed ID: 31345376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
    Pignon JP; Bourhis J; Domenge C; Designé L
    Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A network meta-analysis of the sequencing and types of systemic therapies with definitive radiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN)☆.
    Jerzak KJ; Delos Santos K; Saluja R; Lien K; Lee J; Chan KKW
    Oral Oncol; 2017 Aug; 71():1-10. PubMed ID: 28688674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
    Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
    Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study.
    Driessen CM; de Boer JP; Gelderblom H; Rasch CR; de Jong MA; Verbist BM; Melchers WJ; Tesselaar ME; van der Graaf WT; Kaanders JH; van Herpen CM
    Eur J Cancer; 2016 Jan; 52():77-84. PubMed ID: 26655558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial.
    Tobias JS; Monson K; Gupta N; Macdougall H; Glaholm J; Hutchison I; Kadalayil L; Hackshaw A;
    Lancet Oncol; 2010 Jan; 11(1):66-74. PubMed ID: 19875337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.